Benefits of wearable-based cardiac rehabilitation interventions in secondary prevention of coronary artery disease – a systematic review and meta-analysis
{"title":"Benefits of wearable-based cardiac rehabilitation interventions in secondary prevention of coronary artery disease – a systematic review and meta-analysis","authors":"Theodoros Maximidou, Ute Mons","doi":"10.1016/j.ajpc.2025.101015","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>To assess the benefits of wearable activity trackers in the treatment and care of patients with coronary artery disease (CAD), we performed a systematic review and meta-analysis.</div></div><div><h3>Methods</h3><div>We systematically searched databases and trial registries until March 2025 for randomized controlled trials employing wearable devices (such as activity tracker, pedometer or accelerometer) in cardiac rehabilitation (CR) interventions in patients with CAD. The outcome data were pooled using fixed-effects meta-analysis. Subgroup analyses were conducted for risk of bias, length of follow up, type of wearable and presence of additional interventions. To assess the robustness of the main findings we carried out sensitivity analyses using random effects models and exclusion of outliers. Outcomes of interest were indicators of prognosis and prognostic factors.</div></div><div><h3>Results</h3><div>We included a total of 23 studies and synthesized data from 20 studies in meta-analyses. Meta-analysis of steps per day showed a statistically significant difference favouring the intervention (MD 1060 steps/day, 95 % CI 650 to 1460). Subgroup analyses indicated smaller effects for studies with longer follow-up periods, and for those with high risk of bias. Sensitivity analyses showed robustness of these results. Meta-analyses of rehospitalizations (RR 0.70, 95 % CI 0.52 to 0.95), 6 min walking test (MD 13.06 m, 95 % CI 0.10 to 26.03), and absolute VO<sub>2</sub>peak (MD 0.22 L/min, 95 % CI 0.02 to 0.49) also yielded statistically significant differences favouring the intervention. Findings from other physical performance measures favoured the intervention group without reaching significance. Anthropometric outcomes presented no consistent effect.</div></div><div><h3>Conclusions</h3><div>Our results indicate that wearables significantly enhance effectiveness of CR by increasing physical activity, improving exercise capacity, and reducing rehospitalizations in CAD patients. This suggests that wearable-supported CR programs may positively affect prognosis in CAD. However, further research is needed to corroborate these findings and to ascertain the sustainability of these effects over the long term.</div></div><div><h3>Lay summary</h3><div>In our study, we found that wearable activity trackers significantly increased steps per day, improved exercise capacity and reduced rehospitalizations in patients with coronary artery disease compared to usual care. These findings suggest that the implementation of wearable activity trackers into cardiac rehabilitation might improve clinical outcomes and potentially reduce the burden of the disease.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"23 ","pages":"Article 101015"},"PeriodicalIF":4.3000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266666772500090X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim
To assess the benefits of wearable activity trackers in the treatment and care of patients with coronary artery disease (CAD), we performed a systematic review and meta-analysis.
Methods
We systematically searched databases and trial registries until March 2025 for randomized controlled trials employing wearable devices (such as activity tracker, pedometer or accelerometer) in cardiac rehabilitation (CR) interventions in patients with CAD. The outcome data were pooled using fixed-effects meta-analysis. Subgroup analyses were conducted for risk of bias, length of follow up, type of wearable and presence of additional interventions. To assess the robustness of the main findings we carried out sensitivity analyses using random effects models and exclusion of outliers. Outcomes of interest were indicators of prognosis and prognostic factors.
Results
We included a total of 23 studies and synthesized data from 20 studies in meta-analyses. Meta-analysis of steps per day showed a statistically significant difference favouring the intervention (MD 1060 steps/day, 95 % CI 650 to 1460). Subgroup analyses indicated smaller effects for studies with longer follow-up periods, and for those with high risk of bias. Sensitivity analyses showed robustness of these results. Meta-analyses of rehospitalizations (RR 0.70, 95 % CI 0.52 to 0.95), 6 min walking test (MD 13.06 m, 95 % CI 0.10 to 26.03), and absolute VO2peak (MD 0.22 L/min, 95 % CI 0.02 to 0.49) also yielded statistically significant differences favouring the intervention. Findings from other physical performance measures favoured the intervention group without reaching significance. Anthropometric outcomes presented no consistent effect.
Conclusions
Our results indicate that wearables significantly enhance effectiveness of CR by increasing physical activity, improving exercise capacity, and reducing rehospitalizations in CAD patients. This suggests that wearable-supported CR programs may positively affect prognosis in CAD. However, further research is needed to corroborate these findings and to ascertain the sustainability of these effects over the long term.
Lay summary
In our study, we found that wearable activity trackers significantly increased steps per day, improved exercise capacity and reduced rehospitalizations in patients with coronary artery disease compared to usual care. These findings suggest that the implementation of wearable activity trackers into cardiac rehabilitation might improve clinical outcomes and potentially reduce the burden of the disease.
目的:为了评估可穿戴活动追踪器在冠心病(CAD)患者治疗和护理中的益处,我们进行了系统回顾和荟萃分析。方法:我们系统地检索数据库和试验注册库,直到2025年3月,使用可穿戴设备(如活动跟踪器、计步器或加速度计)对CAD患者进行心脏康复(CR)干预的随机对照试验。结果数据采用固定效应荟萃分析进行汇总。对偏倚风险、随访时间、可穿戴设备类型和是否存在额外干预措施进行了亚组分析。为了评估主要发现的稳健性,我们使用随机效应模型和排除异常值进行了敏感性分析。关注的结果是预后指标和预后因素。结果meta分析共纳入23项研究和20项研究的综合数据。每日步数的荟萃分析显示,支持干预的差异具有统计学意义(MD 1060步数/天,95% CI 650至1460)。亚组分析表明,对于随访时间较长的研究和具有高偏倚风险的研究,影响较小。敏感性分析显示这些结果具有稳健性。再住院率(RR 0.70, 95% CI 0.52 ~ 0.95)、6分钟步行试验(MD 13.06 m, 95% CI 0.10 ~ 26.03)和绝对vo2峰值(MD 0.22 L/min, 95% CI 0.02 ~ 0.49)的meta分析也显示支持干预的统计学显著差异。其他身体表现测量的结果有利于干预组,但没有达到显著性。人体测量结果没有一致的影响。结论可穿戴设备通过增加CAD患者的身体活动、提高运动能力、减少再住院率,显著提高了CR的有效性。这表明可穿戴支持的CR程序可能对CAD的预后有积极影响。然而,需要进一步的研究来证实这些发现,并确定这些影响的长期可持续性。在我们的研究中,我们发现与常规护理相比,可穿戴活动追踪器显著增加了冠状动脉疾病患者每天的步数,提高了运动能力,减少了再住院率。这些发现表明,将可穿戴活动追踪器应用于心脏康复可能会改善临床结果,并有可能减轻疾病负担。